Legend Biotech Corp Number Of Share Options Exercisable In Share-based Payment Arrangement
Legend Biotech Corp (LEGN) had Number Of Share Options Exercisable In Share-based Payment Arrangement of 3.39 million shares as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement · last filed 2026-03-10
- 2025-12-31: Number Of Share Options Exercisable In Share-based Payment Arrangement 3.39M shares.
- 2024-12-31: Number Of Share Options Exercisable In Share-based Payment Arrangement 3.43M shares.
- 2023-12-31: Number Of Share Options Exercisable In Share-based Payment Arrangement 3.47M shares.
- 2022-12-31: Number Of Share Options Exercisable In Share-based Payment Arrangement 3.28M shares.
| Period end | Number Of Share Options Exercisable In Share-based Payment Arrangement | Number Of Share Options Exercisable In Share-based Payment Arrangement as first filed |
|---|---|---|
| 2025-12-31 | 3.39M shares 20-F · filed 2026-03-10 | |
| 2024-12-31 | 3.43M shares 20-F · filed 2026-03-10 | |
| 2023-12-31 | 3.47M shares 20-F · filed 2026-03-10 | |
| 2022-12-31 | 3.28M shares 20-F · filed 2025-03-11 | |
| 2021-12-31 | 2.83M shares 20-F · filed 2024-03-19 | 2.83K shares 20-F · filed 2022-03-31 |
| 2020-12-31 | 4.62M shares 20-F · filed 2023-03-30 | 4.62K shares 20-F · filed 2021-04-02 |
| 2019-12-31 | 2.48K shares 20-F/A · filed 2023-02-17 |